Literature DB >> 13264274

The use of pressure recordings obtained at transthoracic left heart catheterization in the diagnosis of valvular heart disease.

D L FISHER.   

Abstract

Entities:  

Keywords:  CARDIAC VALVES/diseases; HEART

Mesh：

Year:  1955        PMID： 13264274

Source DB:  PubMed          Journal:  J Thorac Surg        ISSN： 0096-5588


× No keyword cloud information.
  8 in total

1.  The transeptal approach to the left atrium in mitral regurgitation.

Authors:  P G NIXON
Journal:  Thorax       Date:  1960-09       Impact factor: 9.139

2.  Ventricular fibrillation during left atrial puncture. Recovery after emergency mitral valvotomy.

Authors:  C BISHOP; M HONEY; D G TAYLOR
Journal:  Br Med J       Date:  1960-07-16

3.  Simplified procedure for combined heard study.

Authors:  H L GADBOYS; S B ROY; J W DOW
Journal:  Ann Surg       Date:  1957-11       Impact factor: 12.969

4.  The experimental creation of chronic mitral insufficiency.

Authors:  S J KUYKENDALL; F H ELLIS; J H GRINDLAY
Journal:  Ann Surg       Date:  1958-01       Impact factor: 12.969

5.  Percutaneous left ventricular puncture in the assessment of aortic stenosis.

Authors:  R BROCK; B B MILSTEIN; D N ROSS
Journal:  Thorax       Date:  1956-09       Impact factor: 9.139

6.  [Chromohemodromographic methods for the quantitative determination of mitral and tricuspid regurgitations].

Authors:  M Condorelli
Journal:  Arch Kreislaufforsch       Date:  1967-04

7.  Fully percutaneous transthoracic left atrial entry and closure as a potential access route for transcatheter mitral valve interventions.

Authors:  Toby Rogers; Kanishka Ratnayaka; William H Schenke; Merdim Sonmez; Ozgur Kocaturk; Jonathan R Mazal; Marcus Y Chen; Moshe Y Flugelman; James F Troendle; Anthony Z Faranesh; Robert J Lederman
Journal:  Circ Cardiovasc Interv       Date:  2015-06       Impact factor: 6.546

8.  THE PREOPERATIVE ASSESSMENT OF MULTIPLE VALVE DISEASE.

Authors:  D KAVANAGH-GRAY; A GERIEN
Journal:  Can Med Assoc J       Date:  1964-10-24       Impact factor: 8.262
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.